Statistics
Publications
1
Citations
15
H-Index
1
Active since
2012
Affiliations
Dan Aleksandrowicz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in apoptosis, immunotherapy, and receptor tyrosine kinase signaling.
Publications per year
2012–2012
1
1
Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera
Manfred Kraus, Yuxun Wang, Dan Aleksandrowicz et al. · PLoS ONE · 2012 · 15 citations · Full text
1–1 of 1